garg

In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel genome editing technologies that can be utilized across multiple application areas.

The global genome editing market size is estimated to grow from USD 3.90 billion in 2024 to USD 14.5 billion by 2035, representing a CAGR of 12.6% during the forecast period until 2035.

The primary purpose of this analysis was to develop a better understanding of the overall potential and capabilities of different technologies available for genome editing. It is worth highlighting that the input data used for this analysis was collated from publicly available sources. Further, at no point should the inferences presented in this section be construed as a recommendation that one technology is better than another.

The following approach was adopted to compare the available genome editing technologies:

• As a starting point, we collated information on the aforementioned parameters for technologies that are being used in genome editing, and thus, were considered for this analysis. 
• The gene editing companies were divided into three peer groups based on their location of headquarters (region-wise), including North America, Europe, and Asia-Pacific, Middle East and North Africa and Latin America.

Further, technology competitiveness was assessed score for gene editing companies using developer power (in terms of years of experience of the developer), technology strength (in terms of type of gene editing technique, gene editing approach, in-silico analysis, type of gene delivery method, type of gene delivery modality, highest phase of drug development supported and application area).

Foreseeing lucrative returns, many public and private investors have made investments worth USD 13.2 billion since 2018; the funding activity is well distributed across different geographical regions.

During our research, we came across 180+ funding instances reported by gene editing companies engaged in the development of genome editing technologies, during the period 2018-2023 (until July), which amounted to a total of USD 13.2 billion. The overall trend of investment in this domain has been very promising. It is worth highlighting that 21% of the total investment (in terms of the amount invested) was made during the last two years.

Majority (42%) of the funding instances observed were through venture capital series. It is worth highlighting that the maximum number of funding instances (75%) were reported by gene editing companies based in North America. Moreover, within Asia-Pacific, maximum funding initiatives were observed to be undertaken by gene editing companies based in China (10%). Further, within Europe, maximum funding instances were undertaken by gene editing companies based in Ireland (3%).

The market opportunity associated with genome editing technologies is anticipated to witness a CAGR of nearly 13% over the next decade.

Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the genome editing market (technologies). As per the base case forecast scenario, the genome editing market size (technologies) is estimated to grow at a CAGR of ~13%, during the forecast period. The market growth of this industry is believed to be primarily driven by the increasing demand for genome editing technologies with high efficiency, which enables the precise editing of the genes. This is anticipated to sustain the demand for genome editing technologies, resulting in lucrative monetization opportunities for gene editing companies.

It is worth mentioning that according to our projections, the global market is dominated by CRISPR technique. This trend is unlikely to change in the forecast period. Further, it is worth mentioning that, as per the market segmentation by gene editing approach, knock-out approach adopted in the genome editing market (technologies) is anticipated to grow at a higher CAGR.

Furthermore, the global market opportunity is expected to be well-distributed across different market segments, including application areas, types of end users and key geographical regions. It is worth mentioning that according to our projections, the global market in North America is likely to capture the majority (77%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Europe is expected to grow at a relatively healthy CAGR, during the forecast period.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/genome-editing-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma/biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.             

We specialize in analyzing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research/consulting services dedicated to serving our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organizations worldwide.

Contact Details

Roots Analysis 

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com 

Website: https://www.rootsanalysis.com/